Wave Life Sciences (WVE) Enterprise Value (2014 - 2026)
Wave Life Sciences (WVE) posted Enterprise Value of -$544.6 million for Q1 2026, up 9.55% on a QoQ basis from -$602.1 million in Q4 2025, and down 124.02% year-over-year from $2.3 billion in Q1 2025.
Wave Life Sciences (WVE) Enterprise Value (2014 - 2026) Analysis & Trends
Wave Life Sciences' Enterprise Value history runs 13 years deep, the most recent figure standing at -$544.6 million for Q1 2026.
- Quarterly Enterprise Value fell 124.02% year-over-year to -$544.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$544.6 million (down 124.02% YoY) and the FY2025 annual result came in at -$602.1 million, down 99.31% from the prior year.
- Enterprise Value was -$544.6 million for Q1 2026 at Wave Life Sciences, up from -$602.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$88.5 million in Q4 2022 and bottomed at -$602.1 million in Q4 2025.
- A 5-year average of -$237.3 million and a median of -$196.2 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 41.22% — and 2023, when it plunged 126.39%.
- Wave Life Sciences' Enterprise Value stood at -$88.5 million in 2022, then sank by 126.39% to -$200.4 million in 2023, then tumbled by 50.77% to -$302.1 million in 2024, then tumbled by 99.31% to -$602.1 million in 2025, then rose by 9.55% to -$544.6 million in 2026.
- Business Quant data shows WVE's Enterprise Value at -$544.6 million in Q1 2026, -$602.1 million in Q4 2025, and -$196.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | -544.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -544.59 Mn |
| Dec 31, 2025 | -602.07 Mn |
| Sep 30, 2025 | -196.20 Mn |
| Jun 30, 2025 | -208.48 Mn |
| Mar 31, 2025 | -243.10 Mn |
| Dec 31, 2024 | -302.08 Mn |
| Sep 30, 2024 | -310.95 Mn |
| Jun 30, 2024 | -154.00 Mn |
| Mar 31, 2024 | -180.90 Mn |
| Dec 31, 2023 | -200.35 Mn |
| Sep 30, 2023 | -139.90 Mn |
| Jun 30, 2023 | -173.00 Mn |
| Mar 31, 2023 | -207.60 Mn |
| Dec 31, 2022 | -88.50 Mn |
| Sep 30, 2022 | -147.04 Mn |
| Jun 30, 2022 | -173.20 Mn |
| Mar 31, 2022 | -161.70 Mn |
| Dec 31, 2021 | -150.56 Mn |
| Sep 30, 2021 | -123.90 Mn |
| Jun 30, 2021 | -143.84 Mn |